Skip to main content
. Author manuscript; available in PMC: 2012 Sep 16.
Published in final edited form as: Vaccine. 2011 Jul 27;29(40):7058–7066. doi: 10.1016/j.vaccine.2011.07.028

Figure 1. Magnitude of positive IFN-γ ELISPOT responses to individual HSV-2 peptide pools in HSV-2+, HSV-1+/2− and HSVneg subjects.

Figure 1

The magnitudes of all positive IFN-γELISPOT responses to any of the 34 HSV-2 peptide pools are displayed in each group of subjects (n=2 for HSVneg, n=8 for HSV-1+/2− and n=22 for HSV-2+ subjects) separated by HSV serostatus. The median magnitude of responses to HSV-2 peptide pools in each group is shown by the bar.